Develops ophthalmology and dermatology niche prescription drugs.

History:

Most of its assets have been acquired by Ista Pharmaceuticals and no longer appears to be a going concern.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
North Carolina

Research Focus:
Disease

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: